gadoteridol

gad·o·ter·i·dol

(gad'ō-ter'i-dol),
A nonionic macrocyclic analogue of gadolinium DOTA; used as a paramagnetic contrast medium in magnetic resonance imaging.
Farlex Partner Medical Dictionary © Farlex 2012
References in periodicals archive ?
To analyze LGE, a 3D inversion-recovery turbo gradient echo sequence was used to obtain images of the left and right ventricles 10 min after injection of 0.2 mmol/kg of gadoteridol (Prohance[R], Bracco-Imaging).
gadoteridol: a pilot study," International Journal of Radiation Oncology, Biology, Physics, vol.
Prospective cohort study of nephrogenic systemic fibrosis in patients with stage 3-5 chronic kidney disease undergoing MRI with injected gadobenate dimeglumine or gadoteridol. AJR Am J Roentgenol.
Evidence points to the fact that gadopentetate dimeglumine, gadoterate, gadoteridol, gadobutrol, gadobenate dimeglumine, and gadoxetate disodium do not cause analytical interference in colorimetric calcium assays, regardless of which colorimetric technique was used [2, 6-9, 11-13].
The images were acquired before contrast, and 1 min, 2 min, and 5 min after the start of 0.1 mmol/kg gadolinium injection at a rate of 2 ml/sec for gadoteridol and 1 ml/sec for gadobutrol.
Closely related diagnostic agents are gadobenate dimeglumine (MultiHance), gadodiamide (Omniscan), gadofosveset (Ablavar), gadopentetate dimeglumine (Magnevist), gadoteridol (Prohance), and gadoversetamide (OptiMARK).
Various MR contrast agents are available on the market--gadodiamide (Omniscan), gadopentetate (Magnascan), gadoteridol (Prohance), etc.--each with its own advantages and disadvantages.
There are five gadolinium-based contrast agents approved for use in the United States: gadodiarnide, gadoversetamide (OptiMARK), gadopentetate dimeglumine (Magnevist), gadoteridol (ProHance), and gadobenate dimeglumine (Multihance).
These agents are gadodimide (Omniscan[R]), gadoversetamide (OptiMARK[R]), gadopentetate dimeglumine (Magnevist[R]), gadoteridol (ProHance[R]), and gadobenate dimeglumine (MultiHance[R]).
Currently, there are four gadolinium-based contrast agents available commercially in the U5: gadodiamide (Omniscan; Amersham Health), gadopentetate dimeglumine (Magnevist; Schering), gadoversetamide (OptiMARK; Mallinckrodt Medical), and gadoteridol (Prohance; Bracco).
Two contrast agents were used, Omniscan (Gadodiamide, GE Healthcare) and ProHance (Gadoteridol, Bracco Diagnostics).